eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » PSPC Alliance - Comment

PSPC Alliance - Comment

Document ID: FDA-2012-N-0170-0002
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 28 2012, at 12:00 AM Eastern Daylight Time
Date Posted: April 16 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: March 7 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: May 31 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fe36aa
View Document:  View as format xml

View Comment

This information is submitted subsequent to a presentation by Mr. Jimmy Mitchell to the FDA panel. Thank you for this opportunity to provide additional information.

Attachments:

PSPC Alliance - Comment Kremzner_FDA_032712

Title:
PSPC Alliance - Comment Kremzner_FDA_032712

View Attachment: View as format pdf

PSPC Alliance - Comment Performance_Report_Synopsis_FINAL

Title:
PSPC Alliance - Comment Performance_Report_Synopsis_FINAL

View Attachment: View as format pdf

PSPC_Alliance_Overview

Title:
PSPC_Alliance_Overview

View Attachment: View as format pdf

PSPC_Organizational_Types_Chart

Title:
PSPC_Organizational_Types_Chart

View Attachment: View as format ppt12 View as format pdf

Related Comments

    View All
Total: 30
PSPC Alliance - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0002

May 31,2012 11:59 PM ET
John Anthony Laczin - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0003

May 31,2012 11:59 PM ET
Association of Clinical Research Organizations (ACRO) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0004

May 31,2012 11:59 PM ET
Regulatory Education and Action for Patients (REAP) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0005

May 31,2012 11:59 PM ET
National Patient Advocate Foundation (NPAF) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0006

May 31,2012 11:59 PM ET